INOXPA INDIA PVT.LTD.

Pune- 411023,

Maharashtra, India

India to touch $27 bn

27/06/2014

India to touch $27 bn

Pharma sales in India to touch $27 bn by 2016: Deloitte

Pharmaceutical sales in India are expected to rise by 14.4 percent to USD 27 billion in 2016 from last year, but the life sciences and health care industry is up against challenges such as quality management and meeting global standards, says a report.

According to "2014 Global Life Sciences Outlook" by consultancy firm Deloitte, pharmaceutical sales in India stood at USD 22.6 billion in 2012, which is expected to rise to USD 23.6 billion in 2013.

It added: "As a per cent of health care expenditures, pharmaceutical sales were 22.6 per cent in 2012; they are expected to reach 23.6% in 2013 and 27 per cent by 2016."

Despite the exponential growth, the report said, India's life sciences and health care industry still faces challenges.

"The outcome of new product patents, drug price control, poor regulatory enforcement, inadequate health care infrastructure, shortage of skilled workforce, increasing patient expectations, ever-changing technology, and quality management and conformance to global standards act as critical barriers in delivering products and services in a sustainable manner," Deloitte said.

India is among the top five emerging pharma markets and has been posting double digit growth on account of several socio-economic factors, including increasing sales of generic medicines, continued growth in chronic therapies, and a greater penetration in rural markets, it said.

"Other growth drivers are heightened health awareness, increasing affluence, changing lifestyles resulting in higher incidence of lifestyle diseases, increasing government expenditure on health care, and a nascent, yet fast growing health insurance industry," the report further said.

In addition, the nation's low cost of production and R&D boosts the efficiency of pharmaceutical companies and its comparative cost advantage enhances pharma exports, it added.

"The worldwide demand for cost-effective generic drugs is leading India to rise as a hub of generic drug manufacturing," the report said.

Further, a number of pharma companies are increasing their operations in India, which has 119 manufacturing sites approved by the USFDA, the highest in any foreign country.

India accounts for over 10 per cent of global pharma production, with over 60,000 generic brands across 60 therapeutic categories; it manufactures more than 400 different active pharmaceutical ingredients (APIs).

On the opportunities for the country's pharma sector, the report said Indian firms can expect to garner USD 40 billion in sales with 46 US drug patents set to expire by 2015. @Source-Business Standard

 

TANK BOTTOM MIXER

TANK BOTTOM MIXERS present a highly hygienic solution for the processes of dispersion, emulsifying, homogenisation and disintegration of a wide range of products in the pharmaceutical industry. Due to the hygienic design, the mixer can be cleaned and sterilised CIP/SIP.

The most common applications include production of ophthalmologic or contact lens solutions, syrups, pill coatings, creams and lotions and injection products.

These mixers can be used either in open or closed tanks at an atmospheric pressure or under pressure/vacuum. The bottom of the tank mixers are designed for applications with highly viscous media and intended to work with anchor type agitators.

Read here for more information:

Materials & Options

Documentations

Contact

Cookies Policy

This website uses cookies. We use cookies to personalise content and ads, to provide social media features and to analyse our traffic. We also share information about your use of our site with our social media, advertising and analytics partners who may combine it with other information that you’ve provided to them or that they’ve collected from your use of their services. However, blocking some types of cookies may affect your experience on the site and the services we can offer. Cookies policy page

Allow all cookies
Allow selection
Necessary (2)
Preferences (0)
Statistics (7)
Marketing (11)
About cookies

Necessary cookies help make a website usable by enabling basic functions like page navigation and access to secure areas of the website. The website cannot function properly without these cookies.

Preference cookies enable a website to remember information that changes the way the website behaves or looks, like your preferred language or the region that you are in.

Statistic cookies help website owners to understand how visitors interact with websites by collecting and reporting information anonymously

Marketing cookies are used to track visitors across websites. The intention is to display ads that are relevant and engaging for the individual user and thereby more valuable for publishers and third party advertisers.

Name Provider Purpose Expiry Type
cc_cookie_accept www.inoxpa.in Stores the user's cookie consent state for the current domain 1 year HTTP
PHPSESSID www.inoxpa.in Preserves user session state across page requests. Session HTTP
collect Google Used to send data to Google Analytics about the visitor's device and behavior. Tracks the visitor across devices and marketing channels. Session Pixel
_ga Google Registers a unique ID that is used to generate statistical data on how the visitor uses the website. 2 years HTTP
_ga_# www.inoxpa.in Used by Google Analytics to collect data on the number of times a user has visited the website as well as dates for the first and most recent visit. 2 years HTTP
_gat_ Google Used by Google Analytics to throttle request rate 1 day HTTP
_gid Google Registers a unique ID that is used to generate statistical data on how the visitor uses the website. 1 day HTTP
fr Facebook Registers a unique ID that is used to generate statistical data on how the visitor uses the website. 3 months HTTP
_fbp Facebook Registers a unique ID that is used to generate statistical data on how the visitor uses the website. 3 months HTTP
IDE Google Used by Google DoubleClick to register and report the website user's actions after viewing or clicking one of the advertiser's ads with the purpose of measuring the efficacy of an ad and to present targeted ads to the user. 1 year HTTP
ads/ga-audiences Google Used by Google AdWords to re-engage visitors that are likely to convert to customers based on the visitor's online behaviour across websites. Session Pixel
VISITOR_INFO1_LIVE YouTube Tries to estimate the users' bandwidth on pages with integrated YouTube videos. 179 days HTTP
YSC YouTube Registers a unique ID to keep statistics of what videos from YouTube the user has seen. Session HTTP
yt-remote-cast-installed YouTube Stores the user's video player preferences using embedded YouTube video. Session HTML
yt-remote-connected-devices YouTube Stores the user's video player preferences using embedded YouTube video. Persistent HTML
yt-remote-device-id YouTube Stores the user's video player preferences using embedded YouTube video. Persistent HTML
yt-remote-fast-check-period YouTube Stores the user's video player preferences using embedded YouTube video. Session HTML
yt-remote-session-app YouTube Stores the user's video player preferences using embedded YouTube video. Session HTML
yt-remote-session-app YouTube Stores the user's video player preferences using embedded YouTube video. Session HTML
yt-remote-session-name YouTube Stores the user's video player preferences using embedded YouTube video. Session HTML
Cookies are small text files that can be used by websites to make a user's experience more efficient. The law states that we can store cookies on your device if they are strictly necessary for the operation of this site. For all other types of cookies we need your permission. This site uses different types of cookies. Some cookies are placed by third party services that appear on our pages. You can at any time change or withdraw your consent from the Cookie Declaration on our website. Learn more about who we are, how you can contact us and how we process personal data in our Privacy Policy. Please state your consent ID and date when you contact us regarding your consent.